Literature DB >> 15905866

Exophthalmos of patients with Graves' disease in Chinese of Taiwan.

C-C Tsai1, H-C Kau, S-C Kao, W-M Hsu.   

Abstract

PURPOSE: To determine the exophthalmos measurements in patients with Graves' disease (GD) and to compare with those of normal subjects among the Chinese of Taiwan.
METHODS: Hertel's exophthalmometry were performed in 163 consecutive adult GD patients and 419 normal subjects. The values of exophthalmos, asymmetry, and the distance between lateral orbital rims (base) were evaluated.
RESULTS: There was a significant difference between GD and normal adults for exophthalmos and asymmetry, with GD patients demonstrating a mean exophthalmos of 18.32 mm and asymmetry of 0.93 mm as compared with 13.91 and 0.55 mm for normal subjects (P<0.001). The mean value of base for GD adults (106.52 mm) is slightly greater than normal subjects (105.82 mm). There was no gender difference in exophthalmometric value or asymmetry in each group. A total of 79 (48.5%) GD patients had exophthalmos greater than the upper limit of normal Chinese in Taiwan (18.6 mm). Asymmetry over 2 mm was observed in 11 (6.7%) patients with GD but in none of the normal subjects.
CONCLUSIONS: GD patients have significant exophthalmos and asymmetry compared to normal subjects. In comparison with previous studies, exophthalmos values for Chinese in Taiwan tend to be lower than those of Caucasians and black-American people, but are close to those of Korean, Japanese, Iranian, Indian, and Asian-American people. Adequate adjustment of normal and abnormal values of exophthalmos according to individual differences is important for the diagnosis of orbital morbidity and management of thyroid associated orbitopathy.

Entities:  

Mesh:

Year:  2006        PMID: 15905866     DOI: 10.1038/sj.eye.6701925

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  17 in total

Review 1.  The evaluation and treatment of graves ophthalmopathy.

Authors:  Marius N Stan; James A Garrity; Rebecca S Bahn
Journal:  Med Clin North Am       Date:  2012-02-22       Impact factor: 5.456

2.  Circulating microRNA predicts insensitivity to glucocorticoid therapy in Graves' ophthalmopathy.

Authors:  Liyun Shen; Fengjiao Huang; Lei Ye; Wei Zhu; Xiaofang Zhang; Shu Wang; Weiqing Wang; Guang Ning
Journal:  Endocrine       Date:  2015-01-15       Impact factor: 3.633

3.  Assessing Graves' ophthalmopathy-specific quality of life in Korean patients.

Authors:  Y J Choi; H T Lim; S J Lee; S Y Lee; J S Yoon
Journal:  Eye (Lond)       Date:  2012-01-13       Impact factor: 3.775

Review 4.  Risk factors for development or deterioration of Graves' ophthalmopathy.

Authors:  Marius N Stan; Rebecca S Bahn
Journal:  Thyroid       Date:  2010-07       Impact factor: 6.568

5.  Normal standards of eye projection in Turkish children 6 to 17 years of age.

Authors:  Turgay Kara; Selim Kurtoglu; M Mumtaz Mazicioglu; Ahmet Ozturk; Mehtap Ozdoğru; Hasan Basri Ustunbas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09-23       Impact factor: 3.117

6.  Acquired Epiblepharon Treated by Lateral Orbital and fat Decompression.

Authors:  Radwan Almousa; Gangadhara Sundar
Journal:  Middle East Afr J Ophthalmol       Date:  2011-01

7.  Prevalence and risk factors for thyroid eye disease among Korean dysthyroid patients.

Authors:  Kyung In Woo; Yoon-Duck Kim; Sang Yeul Lee
Journal:  Korean J Ophthalmol       Date:  2013-11-15

8.  Normal values of Hertel exophthalmometry in a Chinese Han population from Shenyang, Northeast China.

Authors:  Dan Wu; Xin Liu; Di Wu; Xin Di; Haixia Guan; Zhongyan Shan; Weiping Teng
Journal:  Sci Rep       Date:  2015-02-23       Impact factor: 4.379

9.  Severe Ophthalmological Complications of Thyroid Disease are Rare in Ibadan, Southwestern Nigeria: Results of a Pilot Study.

Authors:  Olufunmilola A Ogun; Jokotade O Adeleye
Journal:  Ophthalmol Eye Dis       Date:  2016-03-28

10.  Exophthalmometry value distribution in healthy Lithuanian children and adolescents.

Authors:  Dalia Jarusaitiene; Julija Lisicova; Agne Krucaite; Jurate Jankauskiene
Journal:  Saudi J Ophthalmol       Date:  2015-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.